Medifast (0K05) Ratios
Medifast Ratios
GB:0K05's free cash flow for Q3 2026 was $2.87M. For the 2026 fiscal year, GB:0K05's free cash flow was decreased by $-427.00K and operating cash flow was $3.29M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.69 | 3.34 | 2.43 | 1.58 | 1.81 |
| Quick Ratio | 4.22 | 2.68 | 1.84 | 0.74 | 0.75 |
| Cash Ratio | 2.08 | 1.42 | 1.02 | 0.62 | 0.61 |
| Solvency Ratio | -0.08 | 0.20 | 1.04 | 0.96 | 0.87 |
| Operating Cash Flow Ratio | 0.16 | 0.38 | 1.60 | 1.38 | 0.56 |
| Short-Term Operating Cash Flow Coverage | 1.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 143.59M | $ 140.30M | $ 115.60M | $ 61.62M | $ 111.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.06 | 0.07 | 0.08 | 0.08 |
| Debt-to-Equity Ratio | 0.08 | 0.08 | 0.11 | 0.17 | 0.16 |
| Debt-to-Capital Ratio | 0.08 | 0.07 | 0.10 | 0.14 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.29 | 1.35 | 1.54 | 2.04 | 1.97 |
| Debt Service Coverage Ratio | -0.96 | 0.00 | 0.00 | 221.47 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 263.63 | 0.00 |
| Debt to Market Cap | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.53 | 1.48 | 2.02 | 2.39 | 2.78 |
| Net Debt to EBITDA | -8.43 | -4.54 | -0.52 | -0.31 | -0.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.33% | 73.80% | 72.37% | 71.34% | 73.89% |
| EBIT Margin | -1.46% | 0.63% | 11.79% | 11.56% | 14.17% |
| EBITDA Margin | 2.23% | 2.74% | 13.01% | 12.24% | 14.62% |
| Operating Profit Margin | -3.68% | 0.48% | 11.79% | 11.56% | 14.17% |
| Pretax Profit Margin | -1.46% | 0.63% | 12.01% | 11.51% | 14.16% |
| Net Profit Margin | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% |
| Continuous Operations Profit Margin | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% |
| Net Income Per EBT | 331.12% | 55.22% | 77.19% | 78.00% | 75.89% |
| EBT Per EBIT | 39.67% | 131.58% | 101.89% | 99.60% | 99.95% |
| Return on Assets (ROA) | -7.27% | 0.74% | 32.08% | 45.40% | 41.18% |
| Return on Equity (ROE) | -9.39% | 1.00% | 49.34% | 92.60% | 81.01% |
| Return on Capital Employed (ROCE) | -6.64% | 1.31% | 58.09% | 105.41% | 94.64% |
| Return on Invested Capital (ROIC) | -6.50% | 0.70% | 43.66% | 79.60% | 69.83% |
| Return on Tangible Assets | -7.27% | 0.74% | 32.08% | 45.40% | 41.18% |
| Earnings Yield | -15.92% | 1.09% | 13.59% | 11.12% | 6.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 7.34 | 6.85 | 7.56 | 8.63 | 5.62 |
| Inventory Turnover | 5.47 | 3.72 | 5.43 | 3.85 | 2.21 |
| Fixed Asset Turnover | 10.03 | 12.38 | 15.97 | 21.13 | 18.94 |
| Asset Turnover | 1.50 | 2.12 | 3.46 | 5.06 | 3.83 |
| Working Capital Turnover Ratio | 2.50 | 4.27 | 10.04 | 14.60 | 11.74 |
| Cash Conversion Cycle | 17.04 | 44.79 | 18.97 | 52.37 | 99.98 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 66.76 | 98.10 | 67.27 | 94.69 | 164.91 |
| Days of Payables Outstanding | 49.72 | 53.30 | 48.30 | 42.32 | 64.94 |
| Operating Cycle | 66.76 | 98.10 | 67.27 | 94.69 | 164.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.62 | 2.24 | 13.57 | 17.38 | 8.08 |
| Free Cash Flow Per Share | 0.11 | 1.56 | 12.97 | 15.89 | 5.15 |
| Dividend Paid and CapEx Coverage Ratio | 1.18 | 3.00 | 1.86 | 2.20 | 0.96 |
| Capital Expenditure Coverage Ratio | 1.22 | 3.28 | 22.78 | 11.66 | 2.76 |
| Operating Cash Flow Coverage Ratio | 0.41 | 1.52 | 6.71 | 7.47 | 2.91 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.04 | 0.14 | 0.12 | 0.06 |
| Free Cash Flow Yield | 1.06% | 8.84% | 19.30% | 13.78% | 2.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.28 | 92.74 | 7.36 | 8.99 | 14.94 |
| Price-to-Sales (P/S) Ratio | 0.30 | 0.32 | 0.68 | 0.81 | 1.61 |
| Price-to-Book (P/B) Ratio | 0.59 | 0.92 | 3.63 | 8.33 | 12.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 93.90 | 11.31 | 5.18 | 7.26 | 40.63 |
| Price-to-Operating Cash Flow Ratio | 17.09 | 7.87 | 4.95 | 6.64 | 25.93 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.95 | -0.25 | -1.06 | 0.25 |
| Enterprise Value Multiple | 5.20 | 7.14 | 4.73 | 6.28 | 10.67 |
| Enterprise Value | 44.76M | 117.78M | 659.19M | 1.23B | 2.38B |
| EV to EBITDA | 5.20 | 7.14 | 4.73 | 6.28 | 10.67 |
| EV to Sales | 0.12 | 0.20 | 0.61 | 0.77 | 1.56 |
| EV to Free Cash Flow | 35.84 | 6.92 | 4.67 | 6.91 | 39.44 |
| EV to Operating Cash Flow | 6.52 | 4.81 | 4.46 | 6.32 | 25.17 |
| Tangible Book Value Per Share | 18.11 | 19.22 | 18.51 | 13.85 | 17.30 |
| Shareholders’ Equity Per Share | 18.11 | 19.22 | 18.51 | 13.85 | 17.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -2.31 | 0.45 | 0.23 | 0.22 | 0.24 |
| Revenue Per Share | 35.13 | 55.12 | 98.50 | 142.79 | 130.38 |
| Net Income Per Share | -1.70 | 0.19 | 9.13 | 12.82 | 14.01 |
| Tax Burden | 3.31 | 0.55 | 0.77 | 0.78 | 0.76 |
| Interest Burden | 1.00 | 1.00 | 1.02 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.75 | 0.73 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | -0.37 | 11.71 | 1.49 | 1.36 | 0.58 |
Currency in USD
